TFX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
TFX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The zones of discrimination for M-Score is as such:
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Good Sign:
Beneish M-Score -2.45 no higher than -1.78, which implies that the company is unlikely to be a manipulator.
The historical rank and industry rank for Teleflex's Beneish M-Score or its related term are showing as below:
During the past 13 years, the highest Beneish M-Score of Teleflex was -2.31. The lowest was -2.66. And the median was -2.55.
The historical data trend for Teleflex's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teleflex Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Beneish M-Score | Get a 7-Day Free Trial | -2.31 | -2.54 | -2.66 | -2.36 | -2.45 |
Teleflex Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Beneish M-Score | Get a 7-Day Free Trial | -2.36 | -2.42 | -2.44 | -2.48 | -2.45 |
For the Medical Instruments & Supplies subindustry, Teleflex's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Teleflex's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where Teleflex's Beneish M-Score falls into.
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Teleflex for today is based on a combination of the following eight different indices:
M | = | -4.84 | + | 0.92 * DSRI | + | 0.528 * GMI | + | 0.404 * AQI | + | 0.892 * SGI | + | 0.115 * DEPI |
= | -4.84 | + | 0.92 * 1.0178 | + | 0.528 * 0.9908 | + | 0.404 * 1.0283 | + | 0.892 * 1.0657 | + | 0.115 * 0.9954 | |
- | 0.172 * SGAI | + | 4.679 * TATA | - | 0.327 * LVGI | |||||||
- | 0.172 * 1.0102 | + | 4.679 * -0.012998 | - | 0.327 * 0.9671 | |||||||
= | -2.45 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Dec23) TTM: | Last Year (Dec22) TTM: |
Total Receivables was $443 Mil. Revenue was 773.909 + 746.389 + 743.259 + 710.932 = $2,974 Mil. Gross Profit was 431.417 + 416.311 + 407.823 + 391.38 = $1,647 Mil. Total Current Assets was $1,407 Mil. Total Assets was $7,533 Mil. Property, Plant and Equipment(Net PPE) was $603 Mil. Depreciation, Depletion and Amortization(DDA) was $242 Mil. Selling, General, & Admin. Expense(SGA) was $930 Mil. Total Current Liabilities was $607 Mil. Long-Term Debt & Capital Lease Obligation was $1,839 Mil. Net Income was 31.105 + 137.14 + 111.335 + 76.748 = $356 Mil. Non Operating Income was -52.44 + -0.231 + -1.508 + -2.221 = $-56 Mil. Cash Flow from Operations was 138.856 + 201.618 + 86.1 + 84.064 = $511 Mil. |
Total Receivables was $409 Mil. Revenue was 757.996 + 686.788 + 704.542 + 641.715 = $2,791 Mil. Gross Profit was 422.066 + 373.955 + 388.833 + 346.233 = $1,531 Mil. Total Current Assets was $1,411 Mil. Total Assets was $6,928 Mil. Property, Plant and Equipment(Net PPE) was $578 Mil. Depreciation, Depletion and Amortization(DDA) was $231 Mil. Selling, General, & Admin. Expense(SGA) was $864 Mil. Total Current Liabilities was $581 Mil. Long-Term Debt & Capital Lease Obligation was $1,744 Mil. |
1. DSRI = Days Sales in Receivables Index
Measured as the ratio of Revenue in Total Receivables in year t to year t-1.
A large increase in DSR could be indicative of revenue inflation.
DSRI | = | (Receivables_t / Revenue_t) | / | (Receivables_t-1 / Revenue_t-1) |
= | (443.467 / 2974.489) | / | (408.834 / 2791.041) | |
= | 0.14909 | / | 0.146481 | |
= | 1.0178 |
2. GMI = Gross Margin Index
Measured as the ratio of gross margin in year t-1 to gross margin in year t.
Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.
GMI | = | GrossMargin_t-1 | / | GrossMargin_t |
= | (GrossProfit_t-1 / Revenue_t-1) | / | (GrossProfit_t / Revenue_t) | |
= | (1531.087 / 2791.041) | / | (1646.931 / 2974.489) | |
= | 0.548572 | / | 0.553685 | |
= | 0.9908 |
3. AQI = Asset Quality Index
AQI is the ratio of asset quality in year t to year t-1.
Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.
AQI | = | (1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) | / | (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1) |
= | (1 - (1407.406 + 603.434) / 7532.546) | / | (1 - (1410.983 + 578.416) / 6928.063) | |
= | 0.733046 | / | 0.712849 | |
= | 1.0283 |
4. SGI = Sales Growth Index
Ratio of Revenue in year t to sales in year t-1.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
SGI | = | Sales_t | / | Sales_t-1 |
= | Revenue_t | / | Revenue_t-1 | |
= | 2974.489 | / | 2791.041 | |
= | 1.0657 |
5. DEPI = Depreciation Index
Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
DEPI | = | (Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) | / | (Depreciation_t / (Depreciaton_t + PPE_t)) |
= | (230.59 / (230.59 + 578.416)) | / | (242.118 / (242.118 + 603.434)) | |
= | 0.285029 | / | 0.286343 | |
= | 0.9954 |
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.
SGA expenses index > 1 means that the company is becoming less efficient in generate sales.
SGAI | = | (SGA_t / Sales_t) | / | (SGA_t-1 /Sales_t-1) |
= | (929.867 / 2974.489) | / | (863.748 / 2791.041) | |
= | 0.312614 | / | 0.309472 | |
= | 1.0102 |
7. LVGI = Leverage Index
The ratio of total debt to Total Assets in year t relative to yeat t-1.
An LVGI > 1 indicates an increase in leverage
LVGI | = | ((LTD_t + CurrentLiabilities_t) / TotalAssets_t) | / | ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1) |
= | ((1838.872 + 606.745) / 7532.546) | / | ((1744.46 + 581.492) / 6928.063) | |
= | 0.324673 | / | 0.335729 | |
= | 0.9671 |
8. TATA = Total Accruals to Total Assets
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
TATA | = | (IncomefromContinuingOperations_t | - | CashFlowsfromOperations_t) | / | TotalAssets_t |
= | (NetIncome_t - NonOperatingIncome_t | - | CashFlowsfromOperations_t) | / | TotalAssets_t | |
= | (356.328 - -56.4 | - | 510.638) | / | 7532.546 | |
= | -0.012998 |
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Teleflex has a M-score of -2.45 suggests that the company is unlikely to be a manipulator.
Thank you for viewing the detailed overview of Teleflex's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.
Liam Kelly | officer: EVP & President, International | IDA BUSINESS AND TECHNOLOGY PARK, DUBLIN ROAD, ATHLONE L2 00000 |
Thomas E Powell | officer: Senior Vice President & CFO | C/O TOMOTHERAPY INCORPORATED, 1240 DEMING WAY, MADISON WI 53717 |
Stuart A Randle | director | 585 WEST 500 SOUTH, BOUNTIFUL UT 84010 |
Jaewon Ryu | director | 950 N. GLEBE ROAD, SUITE 700, ARLINGTON VA 22203 |
Neena M Patil | director | JAZZ PHARMACEUTICALS, 3170 PORTER DRIVE, PALO ALTO CA 94304 |
Andrew A Krakauer | director | CANTEL MEDICAL CORP., 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424 |
Cameron P Hicks | officer: Vice President, Global HR | 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087 |
Klasko Stephen K. M.d. | director | 155 SOUTH LIMERICK ROAD, LIMERICK PA 19468 |
Jay White | officer: VP & Pres, Global Commercial | 3015 CARRINGTON MILL BLVD., MORRISVILLE NC 27560 |
Daniel V. Logue | officer: VP, Gen Counsel & Secretary | 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087 |
John Deren | officer: VP & Chief Accounting Officer | 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087 |
James J Leyden | officer: VP, General Counsel, Secretary | C/O INFRASOURCE SERVICES, INC, 500 WEST DUTTON MILL ROAD, ASTON PA 19014 |
James Winters | officer: Vice President, Mfg and Supply | 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087 |
Mario Wijker | officer: Vice President, QARA | 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087 |
Benson Smith | director | C/O ROCHESTER MEDICAL INC, ONE ROCHESTER MEDICAL DDRIVE, STEWARTVILLE MN 55976 |
From GuruFocus
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.